-
The Department of Radiation Oncology is in the Perelman Center. Occupying approximately 80,000 square feet on the Concourse Level, the treatment facilities include the most advanced proton and conventional radiation treatment modalities available as well as public spaces designed for the highest levels of patient comfort.
-
Grand opening of the Proton and SARRP Research Room, March 15, 2017
-
-
-
Welcome to the Department of Radiation Oncology
Message from James M. Metz, MD — Chairman
Penn Radiation Oncology is dedicated to a three-part mission of excellence in patient care, basic and translational research, and the education of residents and students. We are committed to delivering excellence in every area and as such we steadfastly believe that "Excellence is Standard."
Penn Radiation Oncology is one of the most comprehensive radiation oncology programs in the world. The outstanding faculty and staff, combined with Penn’s extensive collection of advanced technology, gives patients access to nearly every treatment option available for their cancer. The broad range of radiation treatments available include proton therapy, intensity-modulated radiation therapy (IMRT), high-dose rate (HDR) and low-dose rate brachytherapy, partial breast irradiation, stereotactic radiosurgery (SRS), and Gamma Knife radiation. With the Abramson Cancer Center of the University of Pennsylvania, Penn Radiation Oncology provides patient care at the Ruth and Raymond Perelman Center for Advanced Medicine and seven community-based sites.
News
- Virtua, Penn Medicine to Bring Proton Therapy to South Jersey
September 26, 2021
A new cancer-killing device, the cyclotron, is being installed at a Camden County hospital, thanks to a partnership between Virtua Health and Penn Medicine. - A FLASH Flood of Research Relating to Ultra-High Dose Rate Radiation Therapy
October 26, 2021
In radiation oncology there is excitement about the delivery of radiation at much higher dose rates than typically used clinically. Constantinos Koumenis, PhD and Amit Maity, MD, PhD provided commentary on the possibility of sparing normal tissues from injury with FLASH proton radiotherapy, as evidenced in pre-clinical studies, looking at the brain, intestine, and skin.